Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Financials Drive Dow

Published 07/14/2014, 04:29 PM
Updated 07/09/2023, 06:31 AM

Encouraged by upbeat earnings from Citigroup (NYSE:C) and multi-billion dollar deals in the pharmaceutical sector, investors shrugged off geo-political pressures and poured back into equities on Monday, driving the Dow Industrials to another record high.

Last week's losses tied to Portugal's banking crisis and worries over Q2 earnings were reversed after Citigroup shares jumped higher on an earnings beat despite a $7 billion judgement levied against the bank by the Justice Department. Health care and industrials were given a shot-in-the arm by M&A deals between Mylan (NASDAQ:MYL) and ABT, AbbVie (NYSE:ABBV) and Shire (NASDAQ:SHPG) and ConAgra Foods (NYSE:CAG) and Inner Mongolia potato processor TaiMei.

In commodities, Gold put in its worst performance this year as the risk-aversion to equities dissipated. The precious metal fell to a 3-week low of $1,302 per ounce, taking Platinum and Silver down in sympathy. Energy prices also fell with Crude Oil at a two-week low and just above $100 per barrel.

Here's Where The Markets Stood At The Close

US MARKETS

GLOBAL SENTIMENT

UPSIDE MOVERS

  • (+) PRGO Israeli media claims investment bank hired to explore strategic alternatives
  • (+) SCOK Changing its name to Clean Synthetic Technologies to highlight focus on clean energy products
  • (+) PGNX FDA approved Salix Pharmaceuticals (SLXP) and Progenics Pharmaceuticals' RELISTOR.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

DOWNSIDE MOVER

  • (-) TRGT Alzheimer disease treatment TC-1734 did not meet the objective of showing superiority to donepezil
  • (-) MRKT Barclays initiates coverage with Equal Weight rating
  • (-) HLIT Cuts Q2 guidance below prior view, street estimates.

After Hours Stock News From Midnight Trader.

Copyright © 2014 MT Newswires, a Division of MidnightTrader, Inc.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.